Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Sep 25;10:1587–1593. doi: 10.2147/JHC.S426174

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Tian et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Changes in case 1 in imaging and laboratory tests during clinical treatment. Enhanced CT images before introducing mHAIC. A 14×11 cm mass is shown in the right liver in the arterial phase (A), portal phase (B) and delayed phase (C). Enhanced CT images after introducing mHAIC. (D) DSA via an implantable port-catheter system, before mHAIC, demonstrated large tumour stains of HCC. (E) The subphrenic artery develops from the beginning of the renal artery and supplies blood to the tumour area. (F and G) After 4 cycles of mHAIC, DSA clipping of the hepatic and subphrenic arteries showed no tumour staining. A 7×6 cm mass is shown in the right liver in the arterial phase (H), portal phase (I) and delayed phase (J). (K) AFP level changes during postoperative mHAIC. (L) Changes in WBC, PLT, and HGB of patients during treatment. (M) Timeline of the treatment process.